Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
Ex-Genzyme CEO gives $10M for MGH cancer center
Boston Globe, September 14, 2011
The former chief executive of biotechnology company Genzyme Corp. is donating $10 million to Massachusetts General Hospital to help establish a center to study personalized cancer treatment.The donation announced Tuesday will help the hospital launch the Henri and Belinda Termeer Center for Targeted Therapies. It will focus on developing and testing new generations of molecular-based drugs that attack specific genetic mutations responsible for various cancers.
Most Viewed
Most Emailed
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Building a Better Healthcare Board
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- Case Study: Advance Care Conversations
- Quiet ORs Better for Patient Safety
- Hard-Nosed About Physician Teamwork
- Hospital Pricing Data Dump Won't Hurt You, Yet
- CMS Releases Hospital Pricing Data
- Tavenner Confirmed as CMS Administrator
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
